PEAK6 Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $956K | Buy |
+2,857
| New | +$956K | ﹤0.01% | 310 |
|
2024
Q2 | – | Sell |
-798
| Closed | -$276K | – | 1083 |
|
2024
Q1 | $276K | Sell |
798
-687
| -46% | -$238K | ﹤0.01% | 579 |
|
2023
Q4 | $479K | Buy |
1,485
+1,482
| +49,400% | +$478K | ﹤0.01% | 520 |
|
2023
Q3 | $1.07K | Hold |
3
| – | – | ﹤0.01% | 1021 |
|
2023
Q2 | $1.08K | Sell |
3
-591
| -99% | -$212K | ﹤0.01% | 937 |
|
2023
Q1 | $284K | Buy |
+594
| New | +$284K | ﹤0.01% | 599 |
|
2022
Q3 | – | Sell |
-5
| Closed | -$2.08K | – | 1663 |
|
2022
Q2 | $2.08K | Sell |
5
-119
| -96% | -$49.5K | ﹤0.01% | 1983 |
|
2022
Q1 | $70K | Sell |
124
-1,886
| -94% | -$1.06M | ﹤0.01% | 1221 |
|
2021
Q4 | $1.52M | Buy |
2,010
+1,205
| +150% | +$910K | ﹤0.01% | 465 |
|
2021
Q3 | $601K | Sell |
805
-722
| -47% | -$539K | ﹤0.01% | 845 |
|
2021
Q2 | $984K | Buy |
1,527
+1,268
| +490% | +$817K | ﹤0.01% | 635 |
|
2021
Q1 | $148K | Buy |
+259
| New | +$148K | ﹤0.01% | 1220 |
|
2020
Q4 | – | Sell |
-1,835
| Closed | -$946K | – | 1454 |
|
2020
Q3 | $946K | Buy |
+1,835
| New | +$946K | ﹤0.01% | 564 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 1233 |
|
2020
Q1 | – | Sell |
-685
| Closed | -$253K | – | 1194 |
|
2019
Q4 | $253K | Buy |
+685
| New | +$253K | ﹤0.01% | 675 |
|
2019
Q1 | – | Sell |
-1,630
| Closed | -$379K | – | 1123 |
|
2018
Q4 | $379K | Buy |
1,630
+834
| +105% | +$194K | ﹤0.01% | 654 |
|
2018
Q3 | $249K | Buy |
+796
| New | +$249K | ﹤0.01% | 730 |
|